Re: Neurotropin clinical trail

[Guest guest]

Joanna took neurotopin for over a year. It helped a little bit. But as

she said every little bit helps cope with the pain.

Rajiv

debgena@... wrote:

> Clinical trial for the treatment of early CRPS I and II

> (Complex Regional Pain Syndromes I and II or

> Reflex Sympathetic Dystrophy and Causalgia)

>

> A National Institutes of Health Study

>

> The National Institutes of Health is seeking selective patients who have

> been recently diagnosed with Complex Regional Pain Syndromes I or II

> (CPRS I or II) for a clinical trial of a potential new treatment for

> these painful disorders. These conditions were formerly known as Reflex

> Sympathetic Dystrophy or Causalgia. This study (NIH Protocol 00-D-0200)

> is a collaborative effort involving investigators in the National

> Institute of Neurological Disorders and Stroke (NINDS), National

> Institute of Dental and Craniofacial Research (NIDCR), and

> Rehabilitation Medicine Department at NIH. The study is designed to

> evaluate the efficacy of Neurotropin as a treatment for early cases of

> CRPS I or II. Neurotropin is a medication that is currently used in

> Japan to treat RSD and other painful conditions and has been reported to

> be most effective in treating recently diagnosed cases of CRPS I or II.

> Therefore, this initial study will focus on patients who have recently

> (within the last year) developed pain in one limb that has been

> diagnosed as CRPS I or II. Subjects are now being recruited for this

> outpatient, double blind, placebo-controlled cross-over study. The study

> requires 11-12 weeks with 3 or 4 short visits to the N.I.H. Clinical

> Center. Eligible patients will be reimbursed for travel and other

> expenses, continue on their current medications as well as the

> experimental agents and will receive optimal medical care at no cost.

> The patient and/or the patient's physician should contact the NIH at the

> address listed below. Upon completion of the study the patient's

> physician will receive a report of the results of the study and

> recommendations for future treatment, as necessary.

>

> Patient Recruitment and Public Liaison Office

> Building 61

> 10 Cloister Court

> Bethesda, land 20892-4754

>

> Toll Free: 1-

> TTY: (local), 1- (toll free)

> Fax:

> Email: prpl@...

>

> A detailed description of the study and information regarding the

> admission criteria are available on the Internet. The simplest way

> reaching the appropriate web page is to search for " Neurotropin " at the

> website http://clinicaltrials.gov

>

> *